Industry

 Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment   IDSMC Did Not Identify Any Safety Concerns Phase 2 Study Target Enrollment Achieved; Final Data and Communication Expected in October 2023 Conference Call and Webcast Today at 2:00 p.m. PDT/5:00 p.m. EDT SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2022 after the market closes on Thursday, August 4, 2022, and host a conference call at 5:00 PM Eastern Time the same day to … [Read more…]

U.S. based cardiac arrhythmia diagnostic medical device system innovator supports CMS Proposed National Payment Framework for Long-Term ECG Monitoring BELLEVUE, Wash.–(BUSINESS WIRE)–#AFib—Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, shares its perspective on recent announcements impacting its served markets. These … [Read more…]

FUKUOKA, Japan–(BUSINESS WIRE)–The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration. Plasmalogens, a class of phospholipids, serve vital roles in the body, including antioxidant action, ion transport, cholesterol efflux and membrane fusion. Plasmalogens are … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Wearable Injectors Market Size, Share & Industry Trends Analysis Report By Therapy, By End User, By Type, By Technology, By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Wearable Injectors Market size is expected to reach $12.9 billion by 2028, rising at a market … [Read more…]

– 74% of healthcare organizations have a strategy to increase APP usage for patients seeking primary care – ALPHARETTA, Ga.–(BUSINESS WIRE)–In a new survey of more than 60 organizations representing over 3,000 Advanced Practice Providers (APPs), Coker Group found that three-fourths of diverse health systems have a strategy in place to increase the use of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global parenteral nutrition market reached a value of US$ 6.3 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 9.3 Billion by 2027, exhibiting a CAGR of 6.71% … [Read more…]

ATLANTA–(BUSINESS WIRE)–#Healthcare–Medxoom, the industry leading Health Benefits and Payments platform, today announced the release of Signals™, an advanced digital service enabling automated collection, scoring and reporting of risk signals for health benefits underwriters. “Healthcare Stop-Loss providers are constrained from delivering the best solutions due to the slow, fragmented nature of the legacy Healthcare Claims and … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, has announced the closing of its $20 million financing round led by an investment partner of VDI shareholder Rainbow Medical. Lawrence C. Best also joined existing investors HBM Healthcare Investments … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Digital Genome Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The global digital genome market is expected to register a CAGR of more than 10% over the forecast period, 2022-2027. The COVID-19 pandemic is an unprecedented health concern and has significantly impacted the digital genome … [Read more…]